We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$127M
AUM Growth
+$8.1M
Cap. Flow
+$2.24M
Cap. Flow %
1.76%
Top 10 Hldgs %
23%
Holding
195
New
32
Increased
37
Reduced
82
Closed
27

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$1.04M
2
PYPL icon
PayPal
PYPL
+$975K
3
PNR icon
Pentair
PNR
+$964K
4
CLX icon
Clorox
CLX
+$826K
5
TT icon
Trane Technologies
TT
+$819K

Sector Composition

Rank Sector Weight
1 Industrials 17.36%
2 Healthcare 16.83%
3 Financials 15.95%
4 Consumer Staples 14.22%
5 Technology 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
76
AbbVie
ABBV
$435B
$548K 0.43%
8,758
+4,950
+130% +$302K
CP icon
77
Canadian Pacific Kansas City
CP
$80.5B
$548K 0.43%
19,200
-985
-5% -$29.1K
HRL icon
78
Hormel Foods
HRL
$13.8B
$536K 0.42%
15,400
-3,400
-18% -$123K
KO icon
79
Coca-Cola
KO
$375B
$525K 0.41%
12,673
-1,000
-7% -$41.6K
SYY icon
80
Sysco
SYY
$40.3B
$524K 0.41%
9,470
-250
-3% -$13K
AZN icon
81
AstraZeneca
AZN
$250B
$521K 0.41%
9,533
+6,420
+206% +$365K
EVHC
82
DELISTED
Envision Healthcare Holdings Inc
EVHC
$519K 0.41%
+8,200
New +$536K
MXL icon
83
MaxLinear
MXL
$6.8B
$516K 0.41%
23,650
+11,073
+88% +$229K
MO icon
84
Altria Group
MO
$114B
$515K 0.4%
7,612
-100
-1% -$6.44K
LEN icon
85
Lennar Class A
LEN
$21.2B
$514K 0.4%
12,575
-3,157
-20% -$128K
VSAT icon
86
Viasat
VSAT
$11.1B
$510K 0.4%
+7,700
New +$552K
WPC icon
87
W.P. Carey
WPC
$16.4B
$510K 0.4%
8,815
+3,012
+52% +$176K
PRXL
88
DELISTED
Parexel International Corp
PRXL
$508K 0.4%
7,725
+3,125
+68% +$196K
APD icon
89
Air Products & Chemicals
APD
$67.6B
$489K 0.38%
3,400
-411
-11% -$57.5K
CCL icon
90
Carnival Corporation Ltd
CCL
$39.7B
$489K 0.38%
9,400
-800
-8% -$40K
AVNS
91
DELISTED
Avanos Medical
AVNS
$488K 0.38%
13,207
-4,450
-25% -$159K
PSX icon
92
Phillips 66
PSX
$81.4B
$475K 0.37%
5,500
LOW icon
93
Lowe's Companies
LOW
$125B
$473K 0.37%
+6,650
New +$470K
COF icon
94
Capital One
COF
$134B
$467K 0.37%
5,350
-600
-10% -$48.4K
CFR icon
95
Cullen/Frost Bankers
CFR
$10.2B
$453K 0.36%
+5,135
New +$412K
POT
96
DELISTED
Potash Corp Of Saskatchewan
POT
$453K 0.36%
+25,050
New +$434K
FRC.PRC.CL
97
DELISTED
First Republic Bank
FRC.PRC.CL
$449K 0.35%
19,325
-700
-3% -$17K
AGN
98
DELISTED
Allergan plc
AGN
$446K 0.35%
2,125
-275
-11% -$57K
NSC icon
99
Norfolk Southern
NSC
$75.1B
$438K 0.34%
4,050
SBUX icon
100
Starbucks
SBUX
$120B
$433K 0.34%
7,800
-800
-9% -$44.3K

Similar funds

New England Research & Management's Q4 2016 Portfolio in Review

As of Q4 2016, New England Research & Management held 195 positions worth $127M, up 6.8% from $119M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q4 2016 filing shows 32 new, 37 increased, 82 reduced and 27 closed positions. Its largest new stake was Estee Lauder: 12,775 shares worth $977K. The largest sale was Bank of America Depository Shares Series E, an estimated $1.05M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q4 2016 buy was Estee Lauder: 12,775 shares worth $977K.
  • New England Research & Management added most to Pentair in Q4 2016, an estimated $964K increase.
  • New England Research & Management's biggest Q4 2016 reduction was United Rentals, cutting an estimated $1.02M.
  • New England Research & Management fully exited Bank of America Depository Shares Series E in Q4 2016, selling an estimated $1.05M.
  • New England Research & Management's ten largest holdings make up 23% of its $127M portfolio in Q4 2016.
  • New England Research & Management opened 32 new positions and closed 27 in Q4 2016.
  • New England Research & Management's portfolio value rose 6.8% quarter-over-quarter to $127M.

Based on New England Research & Management's 13F filing for Q4 2016, filed 6 Feb 2017.